Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
Invasive pathobionts or microbes capable of causing disease can reside deep within the mucosal epithelium of our gastrointestinal tract. Targeted effective antibacterial therapies are needed to combat these disease-causing organisms, many of which may be multidrug resistant.
Guardado en:
Autores principales: | Sabrina I. Green, Carmen Gu Liu, Xue Yu, Shelley Gibson, Wilhem Salmen, Anubama Rajan, Hannah E. Carter, Justin R. Clark, Xuezheng Song, Robert F. Ramig, Barbara W. Trautner, Heidi B. Kaplan, Anthony W. Maresso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9189c0088bb40a09d2c2d58b35fd135 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry
por: Carmen Gu Liu, et al.
Publicado: (2020) -
Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic
<i>Escherichia coli</i>
por: Keiko C. Salazar, et al.
Publicado: (2021) -
Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer
por: Eugeniy P. Smorodin
Publicado: (2021) -
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
por: Jennie Grace Briard, et al.
Publicado: (2018) -
Multiplex glycan bead array for high throughput and high content analyses of glycan binding proteins
por: Sharad Purohit, et al.
Publicado: (2018)